Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia

Author： Amano Y.   Nishimoto T.   Tozawa R.-i.   Ishikawa E.   Imura Y.   Sugiyama Y.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.466, Iss.1, 2003-04, pp. : 155-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging lipid-lowering drugs: squalene synthase inhibitors

By Elsayed Raghda K   Evans Jeffery D  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 309-322

Informa Healthcare

Access to resources Recommend Favorite

Pravastatin: anti-inflammatory effects independent of lipid-lowering effects

By  

Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Effects of hormonal therapy, lipid-lowering agents in elderly women

By  

Inpharma, Vol. 1, Iss. 1630-1631, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Lipid-Lowering Effects of Polymers Derived from Halophenyl Pyrroles

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 6, 2011-07 ,pp. : 544-549

Bentham Science Publishers

Access to resources Recommend Favorite

The Lipid-lowering Effects and Associated Mechanisms of Dietary Phytosterol Supplementation

By  

Current Pharmaceutical Design, Vol. 23, Iss. 34, 2018-01 ,pp. : 5077-5085

Bentham Science Publishers

Access to resources Recommend Favorite